Kenneth Y. Tsai, MD, PhD, FAAD
SESSIONS
S017 The 2025 Debates: Controversies in Dermatology
Mar 7, 2025
•
1:00 PM - 4:00 PM
•
Valencia Ballroom B
S050 Updates in Cutaneous Oncology
Mar 9, 2025
•
1:00 PM - 4:00 PM
•
W303A
F092 Journal Watching
Mar 10, 2025
•
1:00 PM - 3:00 PM
•
W204C
DISCLOSURES
3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);